PHARMACEUTICAL COMPOSITION INCLUDING SGLT-2 INHIBITOR, DPP-IV INHIBITOR AND UNIQUEABLY OTHER ANTI-DIABETIC AGENT, AND ITS APPLICATION

摘要

The application describes a pharmaceutical composition according to claim 1, comprising an SGLT-2 inhibitor, a DPP-IV inhibitor, and a third antidiabetic agent that can be used to treat or prevent one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition, the application describes methods for the prevention or treatment of metabolic disorders and conditions associated with them.